GlassScriptPhysician profile
Brett Joseph King
NPI 1083663488
$5,738.74
in general payments reported to CMS, 2019-2025
10 companies · $1,748 in 2025
The $1,748 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2021: $935 · 2022: $374 · 2023: $304 · 2024: $2,173 · 2025: $1,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,498 · Food and Beverage: $977 · Consulting Fee: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,497.73 |
| Food and Beverage | $977.49 |
| Consulting Fee | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,255.92 | 2023-2025 | Rocklatan |
| Allergan, INC. | $934.63 | 2021 | |
| Thea Pharma INC. | $750.00 | 2024 | |
| Abbvie INC. | $251.58 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $178.85 | 2022 | |
| Pfizer INC. | $126.16 | 2019-2024 | |
| Glaukos Corporation | $82.85 | 2019 | |
| Quidel Corporation | $77.65 | 2019 | |
| Genzyme Corporation | $48.10 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.